Cairo –  Glaxo SmithKline (GSK Egypt) reported a 51.2% year-on-year (YoY) growth in its consolidated net profits, logging EGP 101.41 million in the first nine months of 2020, compared to EGP 67.03 million.

The company’s sales increased to EGP 1.42 billion in the nine-month period ended 30 September from EGP 1.19 billion in the year-ago period, according to a bourse disclosure on Wednesday.

As for standalone business, GSK Egypt achieved net profits of EGP 114.24 million in the January-September period, up from EGP 60.43 million in the corresponding period a year earlier.

During the first half (H1) of 2020, GSK Egypt recorded net profits of EGP 115.96 million, up from EGP 28.847 million in H1-19.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.